recent
advanc
allow
transfer
sensit
precis
rapid
viral
antigen
detect
technologyfrom
sophist
research
laboratori
standardli
equip
clinic
diagnost
facil
possibl
identifi
mani
viral
respiratori
pathogen
directli
clinic
specimen
hr
rapid
antigen
detect
promis
valu
identif
respiratori
virus
antivir
therapi
avail
prevent
employ
isol
precaut
chemoprophylaxi
andlor
immun
whose
presenc
usual
associ
acut
respiratori
diseas
asymptomat
colon
ordinarili
associ
concomit
bacteri
infect
thu
whose
earli
detect
may
allow
withhold
withdraw
antibiot
base
consider
rel
use
rapid
viral
antigen
detect
commonli
encount
respiratori
pathogen
discuss
addit
role
rapid
viral
detect
diagnosi
respiratori
infect
high
risk
versu
otherwis
healthi
individu
explor
recent
laboratori
diagnosi
viral
respiratori
infect
valu
primarili
epidemiolog
tool
rare
direct
benefit
manag
patient
acut
diseas
patient
usual
either
well
dead
viru
could
identifi
technolog
advanc
past
year
allow
transfer
sensit
specif
rapid
viral
antigen
detect
method
tabl
sophist
basic
scienc
laboratori
routin
diagnost
facil
possibl
identifi
mani
respiratori
virus
directli
clinic
sampl
within
day
develop
rapid
viral
diagnost
test
particularli
import
antivir
therapi
becom
avail
viral
antigen
detect
sever
advantag
standard
cultur
serolog
techniqu
obviou
avail
test
result
earli
enough
patient
outcom
may
improv
appropri
chang
therapi
antigen
detect
necessarili
requir
viabl
organ
specimen
handl
requir
stringent
viru
cultur
broaden
avail
viral
diagnost
test
health
care
provid
optim
handl
storag
transport
facil
antigen
detect
method
also
permit
identif
virus
difficult
imposs
cultiv
laboratori
occasion
identif
virus
later
cours
diseas
longer
cultivat
major
advantag
antigen
detect
serolog
diagnosi
viral
respiratori
infect
convalesc
sampl
requir
addit
patient
particularli
highest
risk
seriou
respiratori
diseas
eg
infant
compromis
host
abl
mount
antibodi
respons
viral
infect
chanock
et
al
vargosko
et
al
craft
et
al
although
sensit
specif
antigen
detect
test
vari
one
method
anoth
among
differ
virus
often
approach
even
surpass
standard
cultur
serolog
techniqu
unpreced
sensit
particularli
specif
may
possibl
use
monoclon
antibodi
yolken
nucleic
acid
hybrid
techniqu
engleberg
eisenstein
specif
help
elimin
falseposit
result
caus
nonspecif
reaction
host
antigen
often
seen
previou
antigen
detect
techniqu
year
million
individu
throughout
world
suffer
viral
respiratori
infect
syndrom
list
tabl
caus
serolog
distinct
virus
reason
close
cooper
requir
clinician
virologist
burgeon
new
field
antigen
detect
go
appli
appropri
clinic
set
guidelin
must
develop
choos
virus
sought
patient
test
articl
discuss
factor
consid
determin
valu
antigen
detect
diagnosi
viral
respiratori
infect
clinician
point
view
one
import
factor
consid
choos
virus
sought
antigen
detect
techniqu
avail
antivir
therapi
current
two
drug
avail
use
respiratori
virus
ribavirin
respiratori
syncyti
viru
rsv
amantadin
influenza
infect
report
hayden
gwaltney
although
antigen
detect
method
develop
virus
common
caus
respiratori
infect
tabl
rsv
influenza
viru
use
model
discuss
sinc
antivir
therapi
alreadi
avail
respiratori
syncyti
viru
common
caus
lower
respiratori
infect
primarili
pneumonia
bronchiol
infant
young
children
hall
repeat
infect
rsv
common
symptom
milder
usual
involv
upper
respiratori
tract
older
children
adult
recent
ribavirin
demonstr
effect
rsv
diseas
ribavirin
nucleosid
resembl
guanosin
hall
et
al
potent
inhibitor
viru
replic
vitro
spectrum
activ
includ
rsv
influenza
b
parainfluenza
virus
effect
rout
administr
aerosol
welltoler
signific
toxic
ribavirin
administ
oral
rout
margin
effect
cohen
et
al
togo
et
al
ribavirin
virazol
icn
pharmaceut
costa
mesa
ca
licens
unit
state
rsv
infect
rsv
lower
respiratori
tract
infect
infant
ribavirin
therapi
led
signific
improv
arteri
oxygen
satur
cough
retract
rale
lethargi
hall
et
al
taber
et
al
ribavirin
aerosol
treatment
also
demonstr
effect
rsv
hall
et
al
influenza
knight
et
al
wilson
et
al
influenza
b
infect
adult
ribavirin
show
potenti
activ
parainfluenza
viru
control
clinic
studi
perform
rapid
identif
rsv
perhap
eventu
parainfluenza
influenza
virus
allow
earli
therapi
ribavirin
posit
identif
organ
import
although
ribavirin
safe
quit
cumbersom
administ
aerosol
rout
may
plug
ventil
equip
therapi
monitor
care
thu
even
though
may
rel
broadspectrum
activ
respiratori
virus
ribavirin
use
empir
therapi
patient
possibl
diagnosi
viral
pneumonia
nosocomi
spread
rsv
infect
welldocu
hall
et
al
downham
et
al
hall
et
al
shown
month
rsv
diseas
preval
commun
infant
hospit
reason
wk
develop
nosocomi
rsv
infect
ten
staff
member
also
becam
infect
rsv
high
rate
spread
explain
least
part
fact
infect
infant
still
shed
larg
amount
viru
day
infect
hall
et
al
anoth
studi
demonstr
high
mortal
rate
nosocomi
rsv
infect
infant
congenit
heart
diseas
macdonald
et
al
nurseri
pediatr
ward
outbreak
sever
rsv
berkovich
respiratori
viru
infect
meissner
et
al
downham
et
al
also
report
rapid
diagnosi
rsv
may
prove
use
reduc
transmiss
seriou
respiratori
infect
allow
earlier
implement
isol
cohort
precaut
influenza
viru
signific
caus
morbid
mortal
adult
well
import
etiolog
seriou
lower
respiratori
tract
diseas
pediatr
popul
dougla
bett
usual
associ
epidem
diseas
character
profound
malais
addit
typic
respiratori
symptom
ie
rhiniti
pharyng
cough
seen
respiratori
virus
amantadin
hydrochlorid
antivir
agent
current
licens
treatment
respiratori
virus
unit
state
symmetr
tricycl
amin
specif
inhibit
replic
influenza
virus
oral
form
symmetrel
endo
pharmaceut
wilmington
de
licens
treatment
prevent
influenza
infect
littl
toxic
shortterm
wk
therapi
associ
mild
moder
toxic
mani
organ
system
especi
central
nervou
system
use
sever
week
recommend
effect
prophylaxi
dolin
et
al
rimantadin
analog
amantadin
similar
activ
influenza
less
central
nervou
system
toxic
dolin
et
al
current
licens
use
unit
state
treatment
amantadin
rimantidin
hydrochlorid
result
signific
clinic
improv
influenza
infect
compar
placebo
wingfield
et
al
van
vori
et
al
patient
treat
either
drug
faster
resolut
symptom
abl
resum
normal
activ
sooner
treat
placebo
influenza
diseas
widespread
debilit
monto
cavallaro
earli
institut
antivir
therapi
could
major
econom
social
impact
decreas
time
lost
work
school
healthi
individu
decreas
mortal
rate
high
risk
sever
diseas
could
argu
patient
respiratori
symptom
influenza
outbreak
treat
amantadin
without
perform
antigen
detect
test
howev
although
influenza
outbreak
viru
often
predomin
etiolog
respiratori
symptom
potenti
treatabl
organ
mycaplasma
pneumonia
bacteria
virus
also
may
caus
respiratori
diseas
thu
mani
individu
would
treat
unnecessarili
cdc
guidelin
isol
influenza
adult
state
absenc
epidem
influenza
may
difficult
diagnos
clinic
ground
patient
fulli
recov
time
laboratori
diagnosi
establish
therefor
place
patient
suspect
influenza
isol
precaut
although
theoret
desir
simpli
practic
hospit
garner
simmon
allow
earli
diagnosi
rapid
screen
test
may
play
import
role
prevent
deadli
nosocomiai
outbreak
influenza
infect
particularli
high
risk
area
hospit
coronari
care
intens
care
unit
addit
earli
implement
isol
precaut
may
help
reduc
transmiss
influenza
hospit
staff
earli
diagnosi
influenza
infect
also
allow
earli
institut
amatadin
prophylaxi
contact
amantadin
effect
treatment
influenza
infect
found
effect
prevent
influenza
diseas
cohen
et
al
dolin
et
al
increas
util
amantadin
prophylaxi
recent
propos
immun
practic
advisori
committe
anoth
potenti
use
antigen
detect
earli
recognit
outbreak
influenza
diseas
tile
commun
thu
allow
better
commun
health
plan
like
confirm
presenc
viru
commun
stimul
aggress
implement
immun
program
would
mere
anticip
outbreak
influenza
may
persist
commun
sever
week
immun
program
effect
even
start
first
case
recogn
whether
antivir
prevent
measur
avail
rapid
diagnosi
promis
help
simplifi
patient
care
prevent
unnecessari
expens
andor
invas
diagnost
test
particularli
patient
present
atyp
symptom
dietzman
et
al
kerr
et
al
unlik
bacteri
fungal
diseas
viral
pneumonia
bronchiol
usual
good
correl
upper
lower
respiratori
tract
cultur
thu
mani
patient
rapid
identif
respiratori
viru
nose
throat
specimen
preclud
need
perform
invas
diagnost
procedur
bronchoscopi
transtrach
aspir
open
lung
biopsi
procedur
reserv
patient
whose
antigen
detect
test
neg
suspect
polymicrobi
diseas
certain
circumst
precis
viral
diagnosi
help
limit
antibiot
use
benefit
restrict
antibiot
therapi
includ
decreas
incid
superinfect
fungi
resist
bacteria
well
reduct
acut
side
effect
sensit
predispos
futur
allerg
reaction
ration
decis
limit
antibiot
therapi
howev
made
base
knowledg
pattern
colon
diseas
caus
individu
virus
one
must
know
viru
present
whether
usual
pathogen
whether
associ
asymptomat
colon
data
vari
mean
data
collect
gener
rsv
hall
parainfluenza
viru
hall
influenza
virus
cherri
found
normal
individu
rhinovirus
found
cherri
contrast
adenoviru
may
shed
sever
month
episod
infect
found
respiratori
fecal
sampl
popul
van
der
veen
dijkman
cherri
elveback
et
al
report
presenc
adenoviru
associ
diseas
individu
thu
rsv
parainfluenza
influenza
rhinoviru
found
nasopharynx
patient
respiratori
symptom
highli
like
pathogen
presenc
adenoviru
howev
necessarili
implic
etiolog
agent
rapid
antigen
detect
techniqu
influenc
antibiot
use
also
import
know
often
particular
viru
associ
concomit
bacteri
infect
combin
bacterialvir
infect
document
virus
seen
much
commonli
virus
other
respiratori
syncyti
viru
parainfluenza
viru
infect
seldom
accompani
bacteri
superinfect
elderkin
et
al
hall
hall
hand
influenza
viru
infect
regularli
follow
secondari
bacteri
pneumonia
cherri
dougla
bett
seriou
bacteri
infect
also
report
adenoviru
infect
particularli
militari
recruit
ellenbogen
et
al
spencer
cherri
thu
decis
limit
antibiot
use
simpler
rsv
parainfluenza
virus
influenza
adenovirus
identifi
import
howev
rememb
patient
particularli
serious
ill
high
risk
group
bacteri
fungal
superinfect
polymicrobi
infect
may
indistinguish
viral
diseas
alon
thu
may
possibl
omit
antimicrobi
therapi
organ
simpli
viru
found
anoth
way
viral
antigen
detect
may
aid
manag
acut
respiratori
infect
enabl
physician
give
patient
idea
prognosi
ill
one
main
reason
patient
see
physician
treatment
find
expect
ill
give
specif
viral
etiolog
rather
diagnos
viral
infect
serv
enhanc
physician
credibl
reassur
patient
especi
antibiot
prescrib
tabl
summar
factor
affect
valu
antigen
detect
five
encount
respiratori
virus
first
rapid
diagnosi
import
treatabl
nontreat
virus
second
avail
prevent
measur
chemoprophylaxi
amantadin
influenza
vaccin
influenza
b
virus
militari
recruit
adenovirus
type
help
determin
valu
antigen
detect
prevent
diseas
whether
viru
found
usual
pathogen
associ
bacteri
superinfect
import
also
present
time
rapid
viral
antigen
detect
import
diagnosi
sever
diseas
benign
condit
common
cold
earli
intervent
like
pronounc
effect
morbid
mortal
patient
high
risk
group
develop
sever
viral
respiratori
infect
list
tabl
primari
candid
viral
antigen
detect
test
note
size
group
like
benefit
earli
diagnosi
respiratori
infect
continu
grow
due
improv
medic
care
result
increas
surviv
rate
present
valu
antigen
detect
viral
respiratori
infect
normal
host
limit
manag
sever
diseas
howev
futur
effect
antivir
therapi
becom
avail
routin
outpati
use
possibl
rapid
diagnosi
permit
earli
treatment
even
mild
condit
anoth
import
potenti
benefit
rapid
diagnosi
earli
therapi
viral
respiratori
infect
normal
individu
well
high
risk
decreas
incid
chronic
lung
diseas
follow
lower
respiratori
infect
estim
larg
percentag
chronic
lung
diseas
unit
state
caus
exacerb
viral
lower
respiratori
infect
kattan
et
al
larayacuasay
monto
ross
jame
et
al
krasinski
establish
patient
test
virus
sought
antigen
detect
techniqu
clinician
virologist
must
commun
insur
proper
specimen
collect
specimen
handl
optim
addit
work
togeth
establish
antigen
detect
test
result
made
avail
rapidli
even
though
test
run
short
time
run
certain
day
run
sever
specimen
batch
result
may
avail
time
alter
patient
cours
hand
test
result
may
gener
quickli
laboratori
use
either
reach
clinician
time
fashion
clinician
intend
act
anyway
antigen
detect
test
valu
manag
acut
infect
prevent
nosocomi
diseas
need
simpl
inexpens
enough
perform
rapidli
need
aris
optim
even
night
weekend
holiday
tte
sensit
specif
antigen
detect
test
respiratori
virus
alreadi
reach
rapidli
approach
accept
level
clinic
use
howev
even
extens
educ
campaign
updat
clinician
scope
respiratori
viral
diseas
indic
order
viral
antigen
detect
test
test
particularli
employ
monoclon
antibodi
nucleic
acid
hybrid
could
potenti
specif
littl
practic
use
step
taken
ensur
spectrum
antigen
detect
narrow
includ
employ
one
monoclon
antibodi
detect
given
viru
routledg
et
al
use
monoclon
antibodi
combin
polyclon
antibodi
develop
monoclon
antibodi
capabl
react
broad
rang
antigen
gerhard
et
al
yolken
effect
approach
clinic
diagnosi
probabl
prove
use
screen
panel
test
sever
common
respiratori
virus
although
like
antigen
detect
becom
standard
diagnos
viral
respiratori
diseas
patient
viral
cultiv
still
need
order
perform
antivir
suscept
test
especi
import
antivir
therapi
resist
antivir
agent
becom
preval
serolog
also
need
patient
order
establish
clinic
signific
sinc
presenc
antigen
like
presenc
viru
necessarili
prove
caus
patient
symptom
technolog
avail
detect
viral
antigen
hr
horizon
improv
diagnosi
viral
respiratori
tract
diseas
first
despit
enorm
amount
effort
part
countless
investig
still
test
avail
reliabl
distinguish
viral
bacteri
respiratori
infect
current
effort
help
make
distinct
includ
appli
method
employ
viral
antigen
detect
detect
substanc
interferon
specif
product
viral
infect
clinic
specimen
flower
scott
second
may
possibl
adapt
antigen
detect
technolog
use
vivo
perhap
use
monoclon
antibodi
like
radionuclid
use
gallium
technetium
scan
may
permit
determin
whether
given
viru
relat
ongo
diseas
process
instanc
find
adenoviru
antigen
lung
nasopharnyx
patient
pneumonia
would
provid
good
evid
viru
contribut
diseas
process
use
antigen
detect
technolog
rapid
diagnosi
viral
respiratori
infect
promis
great
valu
certain
clinic
set
potenti
aid
improv
morbid
mortal
rate
acut
viral
respiratori
tract
diseas
permit
earlier
institut
antivir
therapi
also
promis
help
simplifi
patient
manag
import
tool
help
prevent
spread
viral
respiratori
infect
addit
provid
diagnosi
physician
still
confront
acut
ill
patient
help
educ
physician
natur
diseas
caus
specif
virus
thu
help
creat
framework
ration
use
antibiot
antivir
agent
rapid
diagnost
test
also
help
teach
patient
viral
ill
thu
make
easier
understand
accept
medic
care
professor
habermehl
experi
prophylaxi
rsv
particularli
within
hospit
dr
cate
unfortun
agent
avail
rsv
infect
ribavirin
effect
oral
use
elabor
aerosol
mechan
practic
prevent
measur
amantadin
effect
rsv
